70 results
8-K
EX-10.3
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing … for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits
8-K/A
2nkcc0ch qyl
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
8-K/A
EX-99.1
ddhaev82
2 Apr 24
Departure of Directors or Certain Officers
5:12pm